ALLOX
Announced 01 Nov 2026$10.5M · Seed · Manufacturing · Spain
ALLOX is a spin-off of the Centre for Genomic Regulation (CRG) and draws on the expertise and technology developed in the lab of Ben Lehner.
“ALLOX has closed a US$10.5 million (€9.4 million) seed round to expand its experimental and AI-enabled drug discovery platform. The Barcelona company maps functional sites in proteins to find new ways to tackle difficult-to-drug targets. Its approach combines high-throughput genetics and biophysical measurements with predictive models.”
20 more sources tracked. Read the full press release and reporter coverage.
Sign up to read →Investors: ICF - Institut Català de Finances, Asabys Partners.
